Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ravenquest Biomed Inc RVVQF

Healthcare Industrials Drug Manufacturers - Specialty & Generic Cannabis
Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Ravenquest Biomed Inc > RavenQuest Undervalued?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(26)
•••
Post by ourrugon Apr 07, 2019 11:56am
163 Views
Post# 29593578

RavenQuest Undervalued?

RavenQuest Undervalued?

Recent Quarterly Sales (March 28/2019)
 

  • Aphria $21.7 M
    • Market Cap: $3.365 B
  • CannTrust $16.2 M
    • Market Cap: $1.076 B
  • Hexo $13.4 M
    • Market Cap: $1.862 B
  • Organigram $12.4 M
    • Market Cap: $1.455 B
 
RavenQuest is anticipating a run rate of approximately $60 Million starting in July 2019 to July 2020. Their market Cap is $73.568 Million 
 
 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities